Michael Hoosien

Association Between Pre-Ablation Glycemic Control and Outcomes Among Patients With Diabetes Undergoing Atrial Fibrillation Ablation

Eoin Donnellan, Mohamed Kanj, Wael A. Jaber et al. · JACC. Clinical electrophysiology · 2019 · 98 citations

Diabetes Management, Health Policy, Cardiovascular Disease +9

Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States

Apurva O. Badheka, Ankit Chothani, Kathan Mehta et al. · Circulation Arrhythmia and Electrophysiology · 2014 · 68 citations · Full text

Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface

Jianqin Wei, Shaurya Joshi, Svetlana R. Speransky et al. · JCI Insight · 2017 · 42 citations · Full text

Cardiac Muscle, Heart Failure, Cardiovascular Function +16

ST-T Wave Abnormality in Lead aVR and Reclassification of Cardiovascular Risk (from the National Health and Nutrition Examination Survey-III)

Apurva O. Badheka, Nileshkumar Patel, Peeyush Grover et al. · The American Journal of Cardiology · 2013 · 25 citations

Lead Avr, Cardiovascular Epidemiology, Cardiovascular Disease +8

Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy

Neeraj Shah, Apurva O. Badheka, Peeyush Grover et al. · International Journal of Cardiology · 2014 · 19 citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +10